OMERS Administration Corp’s Halozyme HALO Stock Holding History

OMERS Administration Corp’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.76M	Sell	47,989 -25,800	-35%	-$1.76M	0.02%	417
2026 Q1	$4.77M	Buy	73,789 +23,700	+47%	+$1.67M	0.03%	253
2025 Q4	$3.37M	Buy	50,089 +35,289	+238%	+$2.37M	0.02%	252
2025 Q3	$1.09M	Hold	14,800	–	–	0.01%	545
2025 Q2	$770K	Buy	+14,800	New	+$842K	0.01%	565
2024 Q3	–	Sell	-6,200	Closed	-$325K	–	972
2024 Q2	$325K	Buy	+6,200	New	+$272K	﹤0.01%	767

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

OMERS Administration Corp's HALO Position: Q2 2026 in Review

OMERS Administration Corp reduced its Halozyme (HALO) stake by 35% in Q2 2026, selling an estimated $1.76M and leaving 47,989 shares worth $3.76M. The position accounts for 0.02% of the portfolio, ranked #417.

OMERS Administration Corp first reported a position in HALO in Q2 2024 and has held it in 6 quarters since. The position peaked at $4.77M in Q1 2026. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

OMERS Administration Corp held 47,989 shares of Halozyme worth $3.76M as of Q2 2026.
OMERS Administration Corp sold 25,800 Halozyme shares in Q2 2026, an estimated $1.76M.
Halozyme made up 0.02% of OMERS Administration Corp's portfolio in Q2 2026, its #417 holding.
OMERS Administration Corp first reported a position in Halozyme in Q2 2024 and has held it in 6 quarters since.
OMERS Administration Corp's Halozyme position peaked at $4.77M in Q1 2026.
671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on OMERS Administration Corp's 13F filing for Q2 2026, filed 13 Aug 2026.